Antimicrobial resistance in mollicutes: Known and newly emerging mechanisms by Chernov V. et al.
FEMS Microbiology Letters 2018 vol.365 N18
Antimicrobial resistance in mollicutes: Known and newly
emerging mechanisms
Chernov V., Chernova O., Mouzykantov A., Medvedeva E., Baranova N., Malygina T., Aminov R.,
Trushin M.
Kazan Federal University, 420008, Kremlevskaya 18, Kazan, Russia
Abstract
© FEMS 2018. All  rights reserved. This review is devoted to the mechanisms of antibiotic
resistance in mollicutes (class Bacilli, subclass Mollicutes), the smallest self-replicating bacteria,
that can cause diseases in plants, animals and humans, and also contaminate cell cultures and
vaccine preparations. Research in this area has been mainly based on the ubiquitous mollicute
and the main contaminant of  cell  cultures,  Acholeplasma laidlawii.  The omics technologies
applied to this and other bacteria have yielded a complex picture of responses to antimicrobials,
including  their  removal  from  the  cell,  the  acquisition  of  antibiotic  resistance  genes  and
mutations that potentially allow global reprogramming of many cellular processes. This review
provides a brief summary of well-known resistance mechanisms that have been demonstrated
in several mollicutes species and, in more detail, novel mechanisms revealed in A. laidlawii,
including the least explored vesicle-mediated transfer of short RNAs with a regulatory potency.
We hope that this review highlights new avenues for further studies on antimicrobial resistance
in these bacteria for both a basic science and an application perspective of infection control and
management in clinical and research/production settings.
http://dx.doi.org/10.1093/femsle/fny185
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